DiSilvestro P

No ORCID on file · 5 papers in corpus · active 2009-2019
2019
The New England journal of medicine ·doi:10.1056/nejmoa1902626

BackgroundSecondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation.Meth…

2015
Gynecologic Oncology ·doi:10.1016/j.ygyno.2015.09.010

ObjectiveTo evaluate the use of as an aid in the identification of women who can safely undergo conservative, non-surgical management.MethodsAll patients referred to the Program in Women's Oncology for surgery with a pelvic mass are evaluat…

2014
Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·doi:10.1200/jco.2013.54.1987

PurposeRisk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surgic…

2011
Obstetrics and gynecology ·doi:10.1097/aog.0b013e318224fce2

ObjectiveIt is often difficult to distinguish a benign pelvic mass from a malignancy and tools to help referring physician are needed. The purpose of this study was to validate the Risk of Ovarian Malignancy Algorithm in women presenting wi…

2009
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.08.031

IntroductionPatients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk for…